<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="78584">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02082431</url>
  </required_header>
  <id_info>
    <org_study_id>PDX-001-13</org_study_id>
    <nct_id>NCT02082431</nct_id>
  </id_info>
  <brief_title>Long QT and Hearing Loss Registry</brief_title>
  <official_title>Long QT &amp; Hearing Loss Prospective Study Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mednax Center for Research, Education and Quality</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mednax Center for Research, Education and Quality</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the true incidence of long QT (LQT) amongst a
      large cohort of subjects diagnosed with unilateral (right/left) or bilateral sensorineural
      hearing loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine the true incidence of long QT (LQT) amongst a
      large cohort of subjects diagnosed with unilateral (right/left) or bilateral sensorineural
      hearing loss.

      The goal of this study is to answer the following questions:

        1. What is the incidence of an abnormal ECG (QTc &gt; 450 msec) in neonates greater than a
           week of age with either unilateral or bilateral Sensorineural hearing loss?

        2. What percentage of neonates greater than one week of age with either bilateral or
           unilateral sensorineural hearing loss and an abnormal ECG have an identifiable genetic
           mutation?

        3. What is the incidence of an abnormal genetic mutation consistent with long QT
           regardless of the ECG in neonates with bilateral sensorineural hearing loss?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of an abnormal ECG (QTc &gt; 450) in neonates greater than a week of age with either unilateral or bilateral sensorineural hearing loss</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>In neonates &gt; 1 week of age with either bilateral or unilateral sensorineural hearing loss and an abnormal ECG, percentage have an identifiable genetic mutation</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Sensorineural Hearing Loss</condition>
  <condition>Long QT Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Newborn infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All newborns who demonstrate a refer in one or both ears on a routine newborn hearing
             screen

          -  Documentation of informed consent

          -  Inborn

          -  Ability to perform an ABR (auditory brainstem response screen technology) screening
             test

          -  No major anomalies

          -  Subjects' parents willing to provide follow-up data on their child

        Exclusion Criteria:

          -  Newborns with a syndromic cause of hearing loss

          -  Parents unwilling to provide follow-up data

          -  Major congenital anomalies

          -  Major medical problem or conditions. (i.e., hypoxic ischemic encephalopathy (HIE),
             persistent pulmonary hypertension neonate (PPHN), meconium aspiration, etc.)

          -  Congenital cytomegalovirus (CMV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mitchell Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mednax Center for Research, Education and Quality</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Kelleher, MSHS</last_name>
    <phone>800-243-3839</phone>
    <email>amy_kelleher@pediatrix.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jack Jacob</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Banner Good Samaritan Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Martin, MD</last_name>
      <email>Gregory_Martin@pediatrix.com</email>
    </contact>
    <investigator>
      <last_name>Gregory Martin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital &amp; Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kartik Mody, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lawrence and Memorial Hospital</name>
      <address>
        <city>Waterford</city>
        <state>Connecticut</state>
        <zip>06320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Lake, AuD</last_name>
      <email>plake@lmhosp.org</email>
    </contact>
    <investigator>
      <last_name>Patricia lake, AuD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish American Hospital</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Anyebuno, MD</last_name>
      <email>Martin_Anyebuno@pediatrix.com</email>
    </contact>
    <investigator>
      <last_name>Martin Anyebuno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexandria Hospital- Inova Health System</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Holliday, MD</last_name>
      <email>Michael_Holliday@pediatrix.com</email>
    </contact>
    <investigator>
      <last_name>Michael Holliday, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatrix Audiology Services</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Young, AuD</last_name>
      <email>jill_young@pediatrix.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 16, 2016</lastchanged_date>
  <firstreceived_date>March 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sensorineural hearing loss</keyword>
  <keyword>Long QT Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Long QT Syndrome</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
